Panacea Diagnostics
PrivateLast Round
Seed
Jul 24, 2019
Company Overview
Panacea Diagnostics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in July 2019.
Panacea Diagnostics is a medical technology company that develops an adaptable diagnostic platform for biomarker analysis in life sciences and clinical settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panacea Diagnostics Comparables
Compare Panacea Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proteins.1 | 83% | |
| Spear Bio | 83% | |
| Primary Bioscience | 79% |
For institutional investors. Book with your work email.
Panacea Diagnostics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Panacea Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hoxton Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2019
Seed round led by Hoxton Ventures.
For institutional investors. Book with your work email.
Panacea Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Panacea Diagnostics's valuation, stock price, and market status.
Is Panacea Diagnostics a public or private company?
Panacea Diagnostics is a private company.
What is the current stock price of Panacea Diagnostics?
Panacea Diagnostics is a private company, so its shares have no public market price. Caplight tracks Panacea Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Panacea Diagnostics worth (valuation)?
Valuation information for Panacea Diagnostics is not publicly available.
Can I buy Panacea Diagnostics stock?
Panacea Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Panacea Diagnostics's last funding round?
Panacea Diagnostics's most recent funding round was Seed on July 24, 2019.
Who are the main investors in Panacea Diagnostics?
Key investors in Panacea Diagnostics include Hoxton Ventures.
Will Panacea Diagnostics IPO soon?
No public IPO plans have been announced for Panacea Diagnostics.
How can I track Panacea Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Panacea Diagnostics's shares on secondary markets.